Related by context. All words. (Click for frequent words.) 70 suicide ideation 70 suicidal thoughts 69 suicidality 66 depressive symptoms 65 Suicidal ideation 64 comorbid 64 suicide attempters 64 dysthymia 63 suicidal behaviors 63 psychotic symptoms 62 suicidal tendencies 62 Suicidal thoughts 62 suicidal behavior 61 major depressive disorder 61 akathisia 60 hypomanic symptoms 60 divalproex 59 affective disorders 59 psychiatric morbidity 59 unipolar depression 59 psychiatric comorbidities 59 extrapyramidal symptoms 59 comorbid depression 59 psychiatric disorders 58 mood disorders 58 syndromal 58 nondepressed 58 depressive episode 58 suicidal ideations 58 depression suicidal thoughts 58 affective psychoses 58 depressive symptomatology 58 depressive episodes 58 psychological distress 57 attempters 57 anxiety disorders 57 paroxetine 57 CI = 57 comorbidity 57 tricyclic antidepressants 57 euthymic 57 somatic symptoms 57 nonpsychotic 57 psychotic disorders 57 comorbid psychiatric 57 depressive disorders 57 symptom severity 57 psychiatric hospitalization 56 subclinical hypothyroidism 56 depressive symptom 56 depressive disorder 56 emotional lability 56 self injurious 56 nortriptyline 56 depression 56 TEAEs 56 df = 56 severe hypoglycemia 56 adjunctive ABILIFY 56 depression anxiety 56 SSRI SNRI 56 psychiatric comorbidity 56 bipolar depression 56 physiological arousal 56 psychiatric disorder 56 RLAI 55 prodromal symptoms 55 internalizing disorders 55 depression suicidal ideation 55 fluoxetine paroxetine 55 depression suicidality 55 affective psychosis 55 lamotrigine 55 comorbid conditions 55 generalized anxiety disorder 55 nonadherence 55 non affective psychosis 55 borderline personality disorder 55 Depressive symptoms 55 LUTS 55 comorbid anxiety 55 delusions hallucinations 55 schizophrenia schizoaffective disorder 55 neuroleptic 54 sociodemographic characteristics 54 SSRIs 54 impulsivity 54 neurocognitive functioning 54 hyperactivity inattention 54 alexithymia 54 psychosis 54 paroxetine Paxil 54 SSRI antidepressant 54 bipolar disorders 54 bulimia nervosa 54 probands 54 schizophrenia 54 sociodemographic variables 54 Montgomery Åsberg Depression 54 agitation irritability 54 Major Depressive Disorder 54 MMSE scores 54 Suicidal behavior 54 p = .# [002] 54 citalopram 54 Y BOCS 54 HAM D# 54 Abilify aripiprazole 54 schizophrenics 54 NATRECOR R 54 elevated depressive symptoms 54 euthymic patients 54 hypoglycemic events 54 premorbid 53 autistic traits 53 severe hypoglycemic 53 bipolar disorder 53 neuroleptics 53 psychotic illnesses 53 adjunctive placebo 53 confidence interval CI 53 symptomatology 53 pathological gambling 53 ADHD 53 antiepileptic drugs 53 aripiprazole 53 subclinical atherosclerosis 53 affective disorder 53 risperidone Risperdal 53 hyperkalemia 53 schizoaffective disorder 53 posttraumatic stress 53 primidone 53 psychiatric diagnoses 53 % CI #.#-#.# [006] 53 generalized anxiety disorder GAD 53 mental disorders 53 psychopathology 53 arterial thromboembolic events 53 serotonin reuptake inhibitors 53 abdominal adiposity 53 neuroticism 53 migraineurs 53 venlafaxine Effexor 53 venlafaxine XR 53 baseline HbA1c 53 externalizing disorders 53 asymptomatic PAD 53 venous thrombosis 53 comorbid disorders 52 body dysmorphic disorder 52 quetiapine 52 valproate 52 genital arousal 52 hypomania 52 sleep disturbances 52 mania hypomania 52 chlamydial infection 52 paroxetine sertraline 52 bipolar illness 52 thyrotropin levels 52 oxcarbazepine 52 perioperative complications 52 DSM IV Axis 52 microalbuminuria 52 comorbid ADHD 52 T2DM 52 undergone bariatric surgery 52 psychosocial functioning 52 subsyndromal 52 generalized anxiety 52 acamprosate 52 posttraumatic stress disorder PTSD 52 HRQOL 52 carotid IMT 52 intima media thickness 52 fluoxetine 52 nonfatal MI 52 HbA1c levels 52 carotid stenosis 52 prolactin levels 52 colorectal adenomas 52 thromboembolic events 52 including ideation suicidal 52 overactive bladder symptoms 52 antipsychotic efficacy 52 aldosterone antagonist 52 MADRS score 52 psychotic illness 52 puerperal psychosis 52 PTSD symptoms 52 nonsuicidal self injury 52 neuropsychiatric symptoms 52 opioid dependent 52 thromboembolism 52 Comorbid 52 clomipramine 52 HRQoL 52 extrapyramidal disorder 52 fluoxetine Prozac 52 posttraumatic stress disorder 52 hypomanic episodes 52 dysphoric 52 SGAs 52 dysthymic disorder 51 hippocampal volume 51 rehospitalization 51 sd = 51 EFFEXOR XR 51 subclinical cardiovascular disease 51 elevated ALT 51 elevated CRP 51 premenstrual dysphoric disorder 51 Erythropoietic therapies may 51 adolescents 51 ADHD symptoms 51 QIDS SR 51 selective serotonin reuptake inhibitor 51 AUDs 51 Neuroticism 51 EXJADE 51 induced akathisia 51 solifenacin 51 SSRI citalopram 51 psychopathological symptoms 51 mood suicidal ideation 51 paranoid ideation 51 SSRI 51 platelet reactivity 51 % CI #.#-#.# [007] 51 β blocker 51 tricyclic antidepressants TCAs 51 discontinuations due 51 attention-deficit/hyperactivity disorder ADHD 51 pediatric bipolar disorder 51 confidence interval #.#-#.# 51 SRBD 51 recurrent VTE 51 clozapine 51 definite stent thrombosis 51 morphometric vertebral fractures 51 neurocognitive impairment 51 psychiatric hospitalizations 51 antidepressant medications 51 atypical antipsychotic medications 51 OAB symptoms 51 cardiovascular mortality 51 antenatal depression 51 OSAHS 51 myocardial infarction MI 51 opioid misuse 51 hypochondriasis 51 sedatives hypnotics 51 macrovascular 51 comorbidities 51 psychiatric inpatients 51 chronicity 51 dysuria 51 neurodevelopmental impairment 51 schizotypal personality disorder 51 antiepileptic medications 51 aminotransferases 51 postintervention 51 typical antipsychotics 51 reflux symptoms 51 comorbid substance 51 habitual snoring 51 vertebral fracture 51 Oppositional Defiant Disorder 51 citalopram Celexa 51 Paxil paroxetine 51 BMI z 51 SSRI prescriptions 51 myocardial infarctions 51 Interpersonal psychotherapy 51 ziprasidone 51 urinary symptoms 51 Rating Scale MADRS 51 tiagabine 51 MetS 51 ejaculatory control 50 Pathological gambling 50 quetiapine risperidone 50 mood swings irritability 50 PREZISTA r 50 recurrent ischemia 50 hyperarousal 50 partial onset seizures 50 antidepressant medication 50 oxycodone CR 50 left ventricular dysfunction 50 antihypertensive therapy 50 ALT flares 50 nonvertebral fractures 50 atherothrombotic disease 50 RLS symptoms 50 torsades de pointes 50 interpersonal psychotherapy 50 subclinical hyperthyroidism 50 Selective serotonin reuptake inhibitors 50 serotonin syndrome 50 onset seizures 50 bivariate analyzes 50 tricyclic antidepressant 50 BPRS 50 Obsessive compulsive disorder OCD 50 cerebral microbleeds 50 lipid lowering agents 50 manic hypomanic 50 dexmedetomidine 50 postoperative AF 50 psychotic episodes 50 SEROQUEL XR 50 prolonged QT interval 50 T1DM 50 cognitive impairment 50 Keppra R 50 DSM IV diagnosis 50 syncopal 50 clozapine Clozaril 50 conventional antipsychotics 50 gout flare 50 antiepileptic drugs AEDs 50 cholinergic tone 50 subthreshold depression 50 recurrent atrial fibrillation 50 CIN3 50 YMRS 50 incontinence episodes 50 hyperkinetic disorder 50 dissociative symptoms 50 tardive dyskinesia 50 periprocedural MI 50 HAMD 50 annualized relapse 50 primary generalized tonic 50 somatic complaints 50 Duloxetine 50 cerebrovascular events 50 clinically insignificant 50 Generalized Anxiety Disorder 50 DSM IV criteria 50 obsessive compulsive disorder OCD 50 Brief Psychiatric 50 somatoform disorders 50 CI #.#-#.# [001] 50 atherothrombotic 50 generalized tonic clonic seizures 50 hypercalcemia 50 confounding variables 50 unmeasured confounders 50 β blockers 50 GERD symptoms 50 anxiolytic 50 renal dysfunction 50 CVD mortality 50 recurrent DVT 50 hypoglycemic episodes 50 MDD 50 Selective Serotonin Reuptake Inhibitor 50 HbA 1c 50 urge urinary incontinence 50 serum urate 50 hypercalciuria 50 depression irritability 50 hematuria 50 paroxysmal AF 50 thromboembolic 50 desvenlafaxine succinate 50 abnormal lipid 50 COPD exacerbations 50 ATACAND 50 nonsignificant 50 symptom exacerbation 50 syncope 50 % CI #.#-#.# [008] 50 premenstrual syndrome PMS 50 amisulpride 50 ULORIC 49 #HT#A partial agonist 49 receiving ISENTRESS 49 TOPAMAX 49 myoclonic seizures 49 dyspareunia 49 TMS Therapy 49 sotalol 49 prostate cancer CaP 49 escitalopram 49 systemic embolism 49 Psoriasis Area 49 phenytoin 49 quetiapine Seroquel 49 sertraline Zoloft 49 serum uric acid 49 pregabalin 49 decompensation 49 % CI #.#-#.# [003] 49 proteinuria 49 VIIBRYD 49 tryptophan depletion 49 albuminuria 49 homicidal ideation 49 antidepressants 49 Posttraumatic stress disorder PTSD 49 hypercholesterolemia 49 callous unemotional traits 49 mild renal insufficiency 49 nonpsychiatric 49 MMSE score 49 generation antipsychotics 49 psychomotor agitation 49 convergent validity 49 spontaneous preterm birth 49 vasomotor symptoms 49 anticonvulsant medications 49 microscopic hematuria 49 NSTEMI 49 suicidal impulses 49 salivary cortisol 49 Anxiety disorders 49 vesicoureteral reflux 49 depressive illness 49 Index CDAI 49 tricyclics 49 neurocognitive deficits 49 CI -#.# 49 variceal bleeding 49 Montgomery Asberg Depression 49 Prehypertension 49 gestational glucose intolerance 49 Suicidality 49 ziconotide 49 psychosocial variables 49 venlafaxine 49 p = 49 Schizophrenics 49 psychoses 49 tranylcypromine 49 subtrochanteric 49 impulsivity characteristic 49 divalproex sodium 49 Antidepressant 49 carotid intima media 49 laboratory abnormalities 49 white matter hyperintensities 49 PTSD 49 nicotine dependence 49 EDSS scores 49 neuropsychological functioning 49 HbA 1c levels 49 NIHSS score 49 univariate analyzes 49 APTIVUS r 49 mIU L 49 meta analytic review 49 rufinamide 49 venous thromboembolic events 49 renal impairment 49 elevated creatinine 49 antisocial traits 49 olanzapine 49 cryptorchidism 49 subscale scores 49 glycated hemoglobin HbA1c 49 serum BDNF 49 generalized seizures 49 depressive relapse 49 hematologic toxicity 49 dyslipidaemia 49 schizophreniform disorder 49 impulsive behaviors 49 HAM D# scores 49 corticosteroid dose 49 hip BMD 49 asthma exacerbations 49 anxiety irritability 49 NIH CPSI 49 polypharmacy 49 Effexor venlafaxine 49 Prozac Paxil Zoloft 49 psychotropic medication 49 disorder PTSD 49 antidepressant therapy 49 fluvoxamine 49 #q# deletion syndrome 49 events AEs 49 blood Phe levels 49 sexual dysfunctions 49 serum IGF 49 somnolence dizziness 49 subscore 49 lipid parameters 49 haloperidol Haldol 49 Irritability 49 neoadjuvant radiation 49 multivariate analyzes 49 proliferative diabetic retinopathy 49 serum estradiol 49 PANSS scores 49 neurocognitive function 49 testicular tumors 49 treatment emergent adverse 49 STEP BD 49 acute urinary retention 49 anticipatory anxiety 49 colorectal neoplasia 49 cardiometabolic risk 49 nonobstructive 49 neurological abnormalities 49 preterm delivery 49 #,# methylenedioxymethamphetamine 49 disordered eating 48 imipramine 48 apneic episodes 48 antipsychotics 48 apnea hypopnea index 48 MADRS 48 nocturnal enuresis 48 hirsutism 48 nonsignificant difference 48 suicidal 48 neuropsychological deficits 48 GH deficiency 48 disorder FSAD 48 CONCERTA 48 % Confidence Interval 48 stimulant medications 48 SSRI anti depressants 48 parasomnias 48 perimenopausal women 48 depressive 48 serotonin neurotransmission 48 monoamine oxidase inhibitors 48 Celexa citalopram 48 DPNP 48 myopathy rhabdomyolysis 48 subscales 48 microbleeds 48 symptomatic hyponatremia 48 lipid lowering medications 48 Crohn Disease Activity 48 anemia hemoglobin 48 febrile neutropenia 48 somatization 48 alanine aminotransferase 48 hallucinations delusions 48 recurrent UTI 48 phenobarbital phenytoin 48 dissociative disorders 48 varenicline Chantix 48 antipsychotic medications 48 blood phenylalanine Phe 48 Neuropsychiatric Inventory NPI 48 Index FSFI 48 adenotonsillectomy 48 DSM IV 48 gout flares 48 Structured Clinical 48 Subgroup analyzes 48 impaired cognition 48 Mood disorders 48 periprocedural 48 SSRI antidepressants 48 subthreshold 48 advanced neoplasia 48 RLS sufferers 48 cognitive behavioral therapy 48 polyp recurrence 48 familial AF 48 antiarrhythmic drug 48 mg BID dose 48 P = .# 48 hypersomnia 48 % CI #.#-#.# [004] 48 venous thromboembolism VTE 48 serum urate levels 48 potential confounding variables 48 hyperglycemia 48 serotonergic 48 placebo p = 48 thrombotic events 48 SNRIs 48 hypoglycemia 48 sociodemographic factors 48 INVEGA ® 48 binge eating disorders 48 Parkinsonian symptoms 48 asthma exacerbation 48 noncardiac 48 HF hospitalization 48 hypokalemia 48 systolic BP 48 decrements 48 statistically nonsignificant 48 psychotic disorder 48 Antidepressant medications 48 androgen deficiency 48 uncontrolled asthma 48 Social Phobia 48 severe exacerbations 48 fasting triglyceride levels 48 % CI #.#-#.# [002] 48 antidepressant prescribing 48 autonomic dysfunction 48 serologically active patients 48 orthostatic hypotension cataracts 48 serum folate concentrations 48 cardiac toxicity 48 REYATAZ r arm 48 GnRH agonists 48 fetal malformations 48 antisocial behaviors 48 recurrent abdominal pain 48 penile vaginal intercourse 48 postnatally 48 contralateral breast cancer 48 opioid overdose 48 endometrial thickness 48 QT interval prolongation 48 antiepileptics 48 Paroxetine 48 dopamine antagonists 48 posttreatment 48 CONCERTA ® 48 serotonin reuptake inhibitor 48 DAS# [002] 48 Lamotrigine 48 prolactin elevation 48 VADT 48 dapagliflozin plus 48 Prozac fluoxetine 48 intravenous bisphosphonates 48 prodrome 48 ADCS CGIC 48 sertraline 48 mood lability 48 adenoma recurrence 48 HMG CoA reductase inhibitors 48 #mg/day [001] 48 urinary cortisol 48 bipolar affective disorder 48 macrovascular disease 48 Psychotic depression 48 severe hypoglycaemia 48 Rating Scale BPRS 48 hippocampal volumes 48 mcg kg REBETOL 48 sleeplessness anxiety 48 use disorders AUDs 48 hyperactive impulsive 48 paroxetine Seroxat 48 non pharmacological interventions 48 PREZISTA r arm 48 logistic regression analysis 48 tremors anxiousness depression 48 status epilepticus 48 hypoglycaemia 48 rebleeding 48 #q#.# deletion syndrome 48 hypophosphatemia 48 convulsive disorders 48 antidepressive 48 primary aldosteronism 48 guideline concordant 48 parous women 48 frequent awakenings 48 irritability 48 HPA axis 48 Zoloft sertraline 48 HER2 overexpression 48 fragility fracture 48 achieved ACR# 48 virologic failure 48 disorder OCD 48 beta blocker therapy 48 stable angina 48 attention-deficit/hyperactivity disorder 47 meta regression 47 ruboxistaurin 47 confusional 47 glycated hemoglobin levels 47 prescribing antidepressants 47 spontaneous preterm delivery 47 relapse 47 habitual snorers 47 advanced adenomas 47 lipid lowering therapy 47 severe asthma exacerbations 47 behavioral disturbances 47 pCR 47 tic disorder 47 PGTC seizures 47 nocturnal hypoglycemia 47 acarbose 47 quetiapine XR 47 irritability anxiety 47 ejaculatory dysfunction 47 erection hardness 47 prospectively defined 47 opioids 47 apnea hypopnea 47 nonobese 47 urinary tract symptoms 47 airway responsiveness 47 dysmenorrhoea 47 systolic hypertension 47 adrenal insufficiency 47 lipid abnormalities 47 postoperative delirium 47 perinatal depression 47 EEG abnormalities 47 decreased libido 47 QoL 47 internalizing behaviors 47 PREMPRO 47 anti depressant medications 47 tricyclic anti depressants 47 neurocognition 47 activity MAOA 47 serum PSA 47 aminotransferase levels 47 neuropsychological impairments 47 renal toxicity 47 Negative Syndrome 47 XIENCE V PROMUS Stent 47 shorter telomere length 47 A1c levels 47 leukopenia 47 untreated psychosis 47 recurrent venous thromboembolism 47 #.#ng/ml 47 microvascular disease 47 NNT = 47 newer atypical antipsychotics 47 NeuroStar TMS Therapy 47 hypnotics 47 β = 47 albumin excretion 47 CHD mortality 47 HPV prevalence 47 Suicidal Behavior 47 HBeAg negative patients 47 nonadherent 47 Cognitive impairment 47 asthenia 47 abnormal ejaculation 47 dietary calcium intake 47 plasma uric acid 47 hypertensives 47 salmeterol HFA MDI 47 SAPHRIS 47 daytime sleepiness 47 fasting glucose levels 47 upper gastrointestinal bleeding 47 Excessive daytime sleepiness 47 STRATEGY FOR AN OPEN 47 PANSS 47 isotretinoin 47 TAXUS p value 47 underdiagnosis 47 Clinical Psychiatry 47 abrupt discontinuation 47 oral naltrexone 47 psychotherapeutic interventions 47 afib 47 adalimumab 47 Primary endpoints 47 mg BID 47 hypogonadotropic hypogonadism 47 NUCYNTA TM 47 univariate analysis 47 agomelatine 47 concomitant AEDs 47 Exclusion criteria 47 benazepril 47 anticonvulsants 47 hypoglycaemic episodes 47 mL/min/#.# m 2 47 biochemical recurrence 47 hypomanic episode 47 cytogenetic response 47 perioperative mortality 47 LV dysfunction 47 NIHSS 47 bilirubin levels 47 postnatal depression 47 Akathisia 47 posttraumatic 47 SEROQUEL 47 haloperidol 47 TOPAMAX ® 47 antiepileptic drug 47 hypogonadal men 47 serum creatinine levels 47 Depression Inventory 47 thrombophilia 47 diabetes mellitus DM 47 chloride secretion 47 lopinavir r arm 47 Lu AA# 47 depressive illnesses 47 A1C levels 47 neuroimaging studies 47 QTc intervals 47 endometrial cancers 47 hematopoietic cancers 47 systemic corticosteroid 47 eplerenone 47 testosterone supplementation 47 bipolar disorder manic depression 47 SNRI 47 macroalbuminuria 47 prodromal 47 zolmitriptan 47 nonresponders 47 inattention hyperactivity 47 surgically menopausal women 47 cerebrovascular accidents 47 antiretroviral naive 47 serum calcium 47 psychophysiological 47 fluvoxamine Luvox 47 neuropsychiatric 47 proband 47 CCyR 47 aspirin NSAIDs 47 lipid levels 47 sustained ventricular tachycardia 47 auditory hallucinations 47 Nocturia 47 QTc 47 ADHD RS 47 familial aggregation 47 nefazodone 47 lorazepam Ativan 47 PRISTIQ 47 comorbid psychiatric disorders 47 breast tenderness 47 somatoform disorder 47 mmol l 47 pericardial effusion 47 paranoia hallucinations 47 anticonvulsant medication 47 postcoital dysphoria 47 psychopathological disorders 47 lymphocytosis 47 #mg/day [002] 47 TNF antagonist 47 liver histology 47 poststroke 47 depressive mood 47 GH deficient 47 atherothrombotic events 47 bacteriuria 47 reinfarction 47 olanzapine quetiapine 47 Bipolar Disorder 47 postoperative complication 47 unexplained fainting 47 androgen deprivation 47 rheumatoid arthritis osteoarthritis ankylosing 47 tocilizumab 47 chronic prostatitis 47 placebo p 47 TT genotype 47 mg kg dose 47 hypertension 47 Anticonvulsants 47 rCBF 47 tolterodine ER 47 adenoma 47 schizophrenia bipolar 47 atypical ductal hyperplasia 47 atypicals 47 microvascular complications 47 symptomatic VTE 46 Panic Disorder 46 baseline A1C 46 mild renal impairment 46 constipation nausea 46 endometriosis ovarian cysts 46 MGUS 46 coprolalia 46 CDAI score 46 Comorbidity 46 atypical hyperplasia 46 rhinoconjunctivitis 46 logistic regression model 46 XIENCE V vs. 46 persistent pulmonary hypertension 46 receiving APTIVUS r 46 ego dystonic 46 anxiety insomnia 46 cognitive deficits 46 antihypertensive medications 46 antiandrogen 46 bosentan 46 prescribed opioids 46 confounder 46 premenopausal 46 pharmacologic therapies 46 Selective Serotonin Re 46 enuresis 46 attain statistical significance 46 acute psychosis 46 heterozygous familial 46 Known hypersensitivity 46 odds ratios ORs 46 normotensive 46 hypoactive 46 prescribed antidepressant medication 46 Personality disorders 46 fasting insulin 46 prospective longitudinal 46 acute bipolar mania 46 prescribed antidepressants 46 somnolence sedation 46 tapentadol ER 46 episodic migraine 46 HBeAg positive patients 46 coronary calcification 46 psychodynamic therapy 46 WOMAC pain 46 nonfasting triglycerides 46 binary restenosis 46 systolic dysfunction 46 Clinically significant 46 chlorambucil 46 benign breast 46 cardiovascular hospitalization 46 neuropsychiatric adverse 46 recurrent preterm birth 46 MULTAQ 46 LVSD 46 Hypoglycemia 46 ABILIFY Injection 46 OCD 46 carbamazepine 46 transaminase elevations 46 duloxetine 46 risperidone 46 salivary flow 46 nondrinkers 46 BRCA mutation 46 Multivariate analyzes 46 hyperactivity impulsivity 46 OADs 46 lacosamide 46 urate lowering therapy 46 pimozide 46 serum cholesterol 46 Tardive dyskinesia 46 antipsychotic drugs 46 bipolar mania trials 46 selective serotonin reuptake inhibitors 46 trichotillomania 46 manic episodes 46 nonfasting triglyceride levels 46 Personality traits 46 Psychotropic medications 46 familial pancreatic cancer 46 confidence intervals CIs 46 electroconvulsive therapy ECT 46 myocardial infarction 46 sociodemographic 46 ramelteon 46 unprovoked seizures 46 premenstrual dysphoric disorder PMDD 46 intensive statin therapy 46 psychopharmacologic 46 juvenile idiopathic arthritis JIA 46 QT prolongation 46 opiate dependence 46 chronic rhinosinusitis 46 comorbid diagnoses 46 manic depressive illness 46 PCa 46 Triptan 46 unstable angina pectoris 46 hypopituitarism 46 muscle dysmorphia 46 postoperative infections 46 hyperphenylalaninemia HPA due 46 DAS# scores 46 prescription opioid 46 NNRTI resistance 46 neuroleptic drugs 46 supine hypertension 46 dasatinib 46 cardioembolic stroke 46 nocturia 46 serum potassium 46 aged ≥ 46 tic disorders 46 impaired renal 46 atypia 46 psychobiological 46 platelet activation 46 tipranavir ritonavir